DNER and glioblastoma: We demonstrate that the inhibition of BRD2 deposition on ECM gene promoters by RELA K310R mutation, knockdown or using BET-BD2-specific inhibitors led to loss of ECM gene expression, MES transition and invasion of GBM cells, ultimately resulting in decreased macrophage infiltration in in vivo GBM models.